Systematic investigation of gastrointestinal diseases in China (SILC): Validation of survey methodology

BMC Gastroenterology

Volumn 9, Issue , 2009, Pages

  Yan, Xiaoyan ^a   Wang, Rui ^a   Zhao, Yanfang ^a   Ma, Xiuqiang ^a   Fang, Jiqian ^b   Yan, Hong ^c   Kang, Xiaoping ^d   Yin, Ping ^e   Hao, Yuantao ^b   Li, Qiang ^c   Dent, John ^f   Sung, Joseph ^g   Zou, Duowu ^h   Johansson, Saga ⁱ   Halling, Katarina ⁱ   Liu, Wenbin ^j   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d PEKING UNIVERSITY   (China)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^f ROYAL ADELAIDE HOSPITAL   (Australia)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h SECOND MILITARY MEDICAL UNIVERSITY   (China)

ⁱ ASTRAZENECA R AND D   (Sweden)

^j ASTRAZENECA   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CHINA; CONSTRUCT VALIDITY; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HEALTH SURVEY; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SEX DIFFERENCE; SLEEP; VALIDATION PROCESS; ADOLESCENT; BIOPSY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHINA; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 71549135541     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-9-86     Document Type: Article

References (76)

1. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis 2007, 8:179-185. 10.1111/j.1751-2980.2007.00304.x, 17970873.
2. Goh KL, Wong HT, Lim CH, Rosaida MS. Time trends in peptic ulcer, erosive reflux oesophagitis, gastric and oesophageal cancers in a multiracial Asian population. Aliment Pharmacol Ther 2009, 29:774-780. 10.1111/j.1365-2036.2009.03930.x, 19183160.
3. Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD) - a global evidence-based consensus. Am J Gastroenterol 2006, 101:1900-1920. 10.1111/j.1572-0241.2006.00630.x, 16928254.
4. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005, 54:710-717. 10.1136/gut.2004.051821, 1774487, 15831922.
5. Goh K-L. Gastroesophageal reflux disease (GERD) in the East - same as the West. J Clin Gastroenterol 2007, 41(Suppl 2):S54-58.
6. Wong BCY, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006, 4:398-407. 10.1016/j.cgh.2005.10.011, 16616342.
7. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005, 40:275-285. 10.1080/00365520510011579, 15932168.
8. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, Farahmand BY, Winchester CC, Roda E, Bazzoli F. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: Loiano-Monghidoro study. Gut 2008, 57:1354-1359. 10.1136/gut.2007.145177, 18424568.
9. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491. 10.1053/j.gastro.2005.11.061, 16678561.
10. Stanghellini V, Tosetti C, Barbara G, De Giorgio R, Salvioli B, Corinaldesi R. Review article: the continuing dilemma of dyspepsia. Aliment Pharmacol Ther 2000, 14(Suppl 3):23-30. 10.1046/j.1365-2036.2000.00397.x, 11050484.
11. Gwee KA, Chua AS. Functional dyspepsia and irritable bowel syndrome, are they different entities and does it matter?. World J Gastroenterol 2006, 12:2708-2712.
12. Kang JY. Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther 2005, 21:663-676. 10.1111/j.1365-2036.2005.02396.x, 15771752.
13. Hu WH, Wong WM, Lam CL, Lam KF, Hui WM, Lai KC, Xia HX, Lam SK, Wong BC. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther 2002, 16:2081-2088. 10.1046/j.1365-2036.2002.01377.x, 12452941.
14. Chang FY, Lu CL. Irritable bowel syndrome in the 21st century: perspectives from Asia or South-east Asia. J Gastroenterol Hepatol 2007, 22:4-12. 10.1111/j.1440-1746.2006.04672.x, 17201873.
15. Lau EM, Chan FK, Ziea ET, Chan CS, Wu JC, Sung JJ. Epidemiology of irritable bowel syndrome in Chinese. Dig Dis Sci 2002, 47:2621-2624. 10.1023/A:1020549118299, 12452405.
16. Kwan AC, Hu WH, Chan YK, Yeung YW, Lai TS, Yuen H. Prevalence of irritable bowel syndrome in Hong Kong. J Gastroenterol Hepatol 2002, 17:1180-1186. 10.1046/j.1440-1746.2002.02871.x, 12453277.
17. Dai N, Cong Y, Yuan H. Prevalence of irritable bowel syndrome among undergraduates in Southeast China. Dig Liver Dis 2008, 40:418-424. 10.1016/j.dld.2008.01.019, 18339591.
18. Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther 2004, 19:1217-1224. 10.1111/j.1365-2036.2004.01939.x, 15153175.
19. Jeong JJ, Choi MG, Cho YS, Lee SG, Oh JH, Park JM, Cho YK, Lee IS, Kim SW, Han SW, Choi KY, Chung IS. Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol 2008, 14:6388-6394. 10.3748/wjg.14.6388, 2766123, 19009657.
20. Shi R, Xu S, Zhang H, Ding Y, Sun G, Huang X, Chen X, Li X, Yan Z, Zhang G. Prevalence and risk factors for Helicobacter pylori infection in Chinese populations. Helicobacter 2008, 13:157-165. 10.1111/j.1523-5378.2008.00586.x, 18321305.
21. Sung JJY, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009, 29:938-946. 10.1111/j.1365-2036.2009.03960.x, 19220208.
22. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006, 19:449-490. 10.1128/CMR.00054-05, 1539101, 16847081.
23. Fuccio L, Laterza L, Zagari RM, Cennamo V, Grilli D, Bazzoli F. Treatment of Helicobacter pylori infection. BMJ 2008, 337:a1454. 10.1136/bmj.a1454, 18794181.
24. Wu JC. Gastroesophageal reflux disease: an Asian perspective. J Gastroenterol Hepatol 2008, 23:1785-1793. 10.1111/j.1440-1746.2008.05684.x, 19120871.
25. Kim N, Lim SH, Lee KH. No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea. Dig Dis Sci 2001, 46:2724-2732. 10.1023/A:1012783630913, 11768266.
26. Yamamori K, Fujiwara Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, Matsumoto T, Higuchi K, Arakawa T. Prevalence of symptomatic gastro-oesophageal reflux disease in Japanese patients with peptic ulcer disease after eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2004, 20(Suppl 1):107-111. 10.1111/j.1365-2036.2004.01973.x, 15298615.
27. Cao Y, Yan X, Ma X, Wang R, Fu Z, Johansson S, Wallander M-A, He J. Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol 2008, 8:37. 10.1186/1471-230X-8-37, 2533006, 18717991.
28. [Administration division of Shanghai]. ,http://www.xzqh.org/quhua/31sh/
29. The second national agricultural census of Beijing net. , http://www.bjstats.gov.cn/nypc/pcdt/pcxw/200804/t20080416_110349.htm
30. [Administration Division of Xi'an]. ,http://www.xzqh.org/quhua/61sx/01xi'an.htm
31. [Administration division of Wuhan].,http://www.xzqh.org/quhua/42hb/01wuhan.htm
32. Zhenyu H, Ying H, Min C. [Implement the point of view of scientific development to promote the development of the modernization of Wuhan]. J Wuhan Commer Serv Coll 2006, 20:32-37.
33. [Administration division of Guangzhou],http://www.xzqh.org/quhua/44gd/01guangzhou.htm
34. The fifth population census in China. ,http://www.stats.gov.cn/tjsj/ndsj/2006/indexch.htm
35. 1% sample survey data held in 2005 by government in Shanghai. ,http://www.stats-sh.gov.cn/english/index.htm
36. 1% sample survey data held in 2005 by government in Wuhan. ,http://www.whtj.gov.cn/documents/tjnj2006/2/2-5.htm
37. 1% sample survey data held in 2005 by government in Beijing. ,http://www.bjstats.gov.cn/tjnj/2006-tjnj/content/mV11_03-11.htm
38. NBSC 1% sample survey data held in 2005 by government in Guangdong. 2007, Beijing: National Bureau of Statistics of China.
39. Xi'an census 2000. , http://www.stats.gov.cn/tjsj/ndsj/renkoupucha/2000fenxian/htm/table2.htm
40. Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001, 96:52-57. 10.1111/j.1572-0241.2001.03451.x, 11197287.
41. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999, 45(Suppl 2):1-5. 1727570, 10369691.
42. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002, 1593914.
43. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
44. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999, 45:172-180. 1727604, 10403727.
45. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GN, Vieth M. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C and M criteria. Gastroenterology 2006, 131:1392-1399. 10.1053/j.gastro.2006.08.032, 17101315.
46. Fiocca R, Mastracci L, Riddell R, Takubo K, Vieth M, Yerian L, Sharma P, Fernström P, Ruth M. Development and validation of criteria for the recognition of histological lesions in patients with GERD. Gut 2008, 57(Suppl 2):A37.
47. Dent J, Vakil N, Jones R, Reimitz P, Schöning U, Halling K, Junghard O, Lind T. Validation of the reflux disease questionnaire for the diagnosis of gastroesophageal reflux disease in primary care. Gut 2007, 56(Suppl 3):A75.
48. Veldhuyzen van Zanten S, Armstrong D, Barkun A, Junghard O, White RJ, Wiklund IK. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire. Aliment Pharmacol Ther 2007, 25:1087-1097.
49. Johnsson F, Hatlebakk J, Klintenberg AC, Román J. The symptom relieving effect of esomeprazole 40 mg daily in patients with heartburn. Gastroenterology 2001, 120(Suppl):A437.
50. Chinese GERD Study Group Value of reflux diagnostic questionnaire in the diagnosis of gastroesophageal reflux disease. Chin J Dig Dis 2004, 5:51-55. 10.1111/j.1443-9573.2004.00155.x, 15612657.
51. Kwan AC, Bao TN, Chakkaphak S, Chang FY, Ke MY, Law NM, Leelakusolvong S, Luo JY, Manan C, Park HJ, Piyaniran W, Qureshi A, Long T, Xu GM, Xu L, Yuen H. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 2003, 18:796-802. 10.1046/j.1440-1746.2003.03081.x, 12795751.
52. Shinozaki M, Kanazawa M, Sagami Y, Endo Y, Hongo M, Drossman DA, Whitehead WE, Fukudo S. Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index. J Gastroenterol 2006, 41:491-494. 10.1007/s00535-006-1799-9, 16799892.
53. Whitehead WE, Bassotti G, Palsson O, Taub E, Cook EC, Drossman DA. Factor analysis of bowel symptoms in US and Italian populations. Dig Liver Dis 2003, 35:774-783. 10.1016/S1590-8658(03)00456-0, 14674667.
54. Li L, Wang HM, Shen Y. Chinese SF-36 health survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health 2003, 57:259-263. 10.1136/jech.57.4.259, 1732425, 12646540.
55. Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:1159-1165. 10.1016/S0895-4356(98)00107-3, 9817133.
56. Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M, Thunedborg K. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:1167-1170. 10.1016/S0895-4356(98)00108-5, 9817134.
57. Johns MW. Reliability and factor analysis of the Epworth sleepiness scale. Sleep 1992, 15:376-381.
58. Chung KF. Use of the Epworth Sleepiness Scale in Chinese patients with obstructive sleep apnea and normal hospital employees. J Psychosom Res 2000, 49:367-372. 10.1016/S0022-3999(00)00186-0, 11164062.
59. Data entry, data management and basic statistical analysis system. , http://www.epidata.dk
60. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey manual and interpretation guide. 1993, Boston: New England Medical Center, The Health Institute.
61. McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32:40-66. 10.1097/00005650-199401000-00004, 8277801.
62. Gandek B, Ware JE, Aaronson NK, Alonso J, Apolone G, Bjorner J, Brazier J, Bullinger M, Fukuhara S, Kaasa S, Leplege A, Sullivan M. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:1149-1158. 10.1016/S0895-4356(98)00106-1, 9817132.
63. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16:297-334.
64. Fang J. Medical statistics and computer experiments. 2005, Singapore: Stallion Press.
65. Hinkle DE, Jurs SG, Wiersma W. Applied statistics for the behavioural sciences. 1988, Boston: Houghton Mifflin, 2.
66. World Health Organization Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163. 10.1016/S0140-6736(03)15268-3, 14726171.
67. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Engstrand L, Stolte M, Vieth M, Walker M, Agreus L. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008, 43:1448-1455. 10.1080/00365520802273025, 18663663.
68. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999, 45(Suppl 2):II43-47. 1766683, 10457044.
69. Drossman DA, Corazziari E, Talley N, Thompson WG, Whitehead WE. Rome II: A multinational consensus document on functional gastrointestinal disorders. Gut 1999, 45(Suppl 2):II1-II81. 1766692, 10457038.
70. China sees soaring migrant population. , http://www.chinagate.cn/english/news/49142.htm
71. Shaw M, Dent J, Beebe T, Junghard O, Wiklund I, Lind T, Johnsson F. The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes 2008, 6:31-36. 10.1186/1477-7525-6-31, 2390523, 18447946.
72. Chang DF, Chun CA, Takeuchi DT, Shen H. SF-36 health survey: tests of data quality, scaling assumptions, and reliability in a community sample of Chinese Americans. Med Care 2000, 38:542-548. 10.1097/00005650-200005000-00010, 10800980.
73. Ren XS, Amick B, Zhou L, Gandek B. Translation and psychometric evaluation of a Chinese version of the SF-36 Health Survey in the United States. J Clin Epidemiol 1998, 51:1129-1138. 10.1016/S0895-4356(98)00104-8, 9817130.
74. Tseng HM, Lu JF, Gandek B. Cultural issues in using the SF-36 Health Survey in Asia: results from Taiwan. Health Qual Life Outcomes 2003, 1:72. 10.1186/1477-7525-1-72, 385291, 14641915.
75. Lam CL, Gandek B, Ren XS, Chan MS. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol 1998, 51:1139-1147. 10.1016/S0895-4356(98)00105-X, 9817131.
76. China statistical yearbook. , http://www.stats.gov.cn/tjsj/ndsj/2008/indexeh.htm